
Boehringer Ingelheim Chemicals Closing Virginia API Manufacturing Facility
The closure will impact 240 employees through a multistage process starting in December 2013.
The Petersburg facility manufactures active ingredients for the pharmaceutical industry. BICI’s parent company, Boehringer Ingelheim, conducted a review of its current manufacturing capabilities worldwide, as well as needs in the industry, and determined that it had more capacity than the marketplace can sustain. BICI considered selling the facility but was unable to find a buyer. The company said it will begin working with its customers immediately to ensure a smooth transition to new suppliers.
Source:
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





